The mechanism by which T cell receptor specificity determines the outcome of the CD4/CD8 lineage decision in the thymus is not known. An important clue is the fact that major histocompatibility complex (MHC)-I–signaled thymocytes paradoxically appear as CD4+8lo transitional cells during their differentiation into CD8+ T cells. Lineage commitment is generally thought to occur at the CD4+8+ (double positive) stage of differentiation and to result in silencing of the opposite coreceptor gene. From this perspective, the appearance of MHC-I–signaled thymocytes as CD4+8lo cells would be due to effects on CD8 surface protein expression, not CD8 gene expression. But contrary to this perspective, this study demonstrates that MHC-I–signaled thymocytes appear as CD4+8lo cells because of transient down-regulation of CD8 gene expression, not because of changes in CD8 surface protein expression or distribution. This study also demonstrates that initial cessation of CD8 gene expression in MHC-I–signaled thymocytes is not necessarily indicative of commitment to the CD4+ T cell lineage, as such thymocytes retain the potential to differentiate into CD8+ T cells. These results challenge classical concepts of lineage commitment but fulfill predictions of the kinetic signaling model.
Skip Nav Destination
Article navigation
16 June 2003
Article Contents
Article|
June 16 2003
Unraveling a Revealing Paradox : Why Major Histocompatibility Complex I–signaled Thymocytes “Paradoxically” Appear as CD4+8lo Transitional Cells During Positive Selection of CD8+ T Cells
Remy Bosselut,
Remy Bosselut
1Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Terry I. Guinter,
Terry I. Guinter
2Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Susan O. Sharrow,
Susan O. Sharrow
2Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Alfred Singer
Alfred Singer
2Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Remy Bosselut
1Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Terry I. Guinter
2Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Susan O. Sharrow
2Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Alfred Singer
2Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Address correspondence to Alfred Singer, Experimental Immunology Branch, National Cancer Institute, Building 10, Room 4B36, Bethesda, MD 20892. Phone: 301-496-5461; Fax: 301-496-0887; E-mail: [email protected]
*
Abbreviations used in this paper: DP, double positive; hCD2, human CD2.
Received:
January 31 2003
Revision Received:
April 20 2003
Accepted:
April 20 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (12): 1709–1719.
Article history
Received:
January 31 2003
Revision Received:
April 20 2003
Accepted:
April 20 2003
Citation
Remy Bosselut, Terry I. Guinter, Susan O. Sharrow, Alfred Singer; Unraveling a Revealing Paradox : Why Major Histocompatibility Complex I–signaled Thymocytes “Paradoxically” Appear as CD4+8lo Transitional Cells During Positive Selection of CD8+ T Cells . J Exp Med 16 June 2003; 197 (12): 1709–1719. doi: https://doi.org/10.1084/jem.20030170
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement